Novocol Healthcare Expands Injectable Capabilities with Investment in Device Company Duoject

Posted: November 3, 2015
Edited by Dentaltown staff

CAMBRIDGE, CANADA—Novocol Healthcare (NHI), a subsidiary of Septodont, a world leader in sterile injectable manufacturing, has announced the acquisition of a majority stake in Duoject Medical Systems (Duoject), a supplier of innovative medical devices.

The synergy between the companies will bring additional value to NHI development projects, and will allow NHI to offer a broad array of injection devices and reconstitution systems to its pharmaceutical filling customers.

“The acquisition of Duoject enables NHI to offer a more complete and differentiated line of drug filling and delivery solutions to our customers. The acquisition of Duoject transforms NHI’s injectable business from a sterile injectable filling company to a one-stop source for device design and development, and pharmaceutical filling and supply of unique injectable products.” said Todd Beechey, President of NHI.

For more information about NHI, visit Novocolhealthcare.com. For more information about Duoject, visit Duoject.com.
Views: 255
Sponsors
Townie Perks
Townie® Poll
Do you do more or less endo procedures since you started practicing?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@dentaltown.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450